v3 Template
T

Theolytics

Biotechnology
Founded
--
Employees
--
Total Funding
$51.6M
Funding Rounds
3
Last Funding
2024-09-02

About Theolytics

Theolytics is a biotech company focused on transforming patients' lives by harnessing viruses to combat cancer. Their mission is to provide innovative therapies that offer lasting cures through world-leading science and a dedicated team.

Products & Services

Oncolytic Viral Therapy for Ovarian Cancer:A lead program focused on discovering novel therapies for ovarian cancer using oncolytic viruses that selectively kill cancer cells, support immune system detection, and clear tumors.
Discovery Platforms:Platforms that utilize viruses to identify therapies optimized for specific patient populations, aiming for lasting cures.

Specialties

Virology Cancer Biology Immunology Bioinformatics Molecular Biology Oncolytic Viral Therapy

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant 		A: 2600000
MR: -
FA: £2M
FAN: 2600000 		D: 2024-09-02
FD: 2024-09-02 		1 investors
2 RT: Latest financing round
T: -
FT: Latest financing round 		A: 24500000
MR: -
FA: £19M ($24.5M)
FAN: 24500000 		D: 2024-04-17
FD: 2024-04-17 		6 investors
3 RT: Equity Financing
T: -
FT: Equity Financing 		A: 24500000
MR: -
FA: £19M ($24.5M)
FAN: 24500000 		D: 2024-04-17
FD: 2024-04-17 		6 investors
Grant Latest
2024-09-02
$2.6M
1 investor (Pro only)
Latest financing round 2024-04-17
$24.5M
Equity Financing 2024-04-17
$24.5M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Theolytics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro